Acta Pharmaceutica Sinica B-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2023-12-01 ms5000001903106247 来自新疆

审稿速度:3.0
经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！

34 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2021-09-06 ms3000000025379696

偏重的研究方向：药理学
经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？

182 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2023-07-25 Mr.Curiosity 来自安徽省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：生物;药理
经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久

35 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2023-06-25 ms5000000162909074 来自天津

避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间

58 0

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2023-05-14 ffddvddvgh 来自陕西省

偏重的研究方向：药理学;药学
经验分享：这个期刊，补充材料怎么上传？没有专门的一栏

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2022-11-05 ms3000002005636194

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：药理
经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊

55 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2023-04-25 ms6000002140643083 来自安徽省

。

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2023-04-25 ms6000002140643083 来自安徽省

。

40 0

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2018-06-20 奔跑在Nature路上的小兽医

审稿速度:3.0 | 投稿命中率:50.0
经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu

243 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2172318, encodeId=806e21e231891, content=审稿速度:3.0 经验分享：投过去一个多月才送审，之后将近两个月送审意见回来了，一共十个意见，完全就是小修的状态，结果编辑不说明原因直接拒稿！这点非常让人不理解！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e3b5688776, createdName=ms5000001903106247, createdTime=Fri Dec 01 14:17:23 CST 2023, time=2023-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1015122, encodeId=c16f101512290, content=偏重的研究方向：药理学 经验分享：刚投了一篇，到今天有一周了，还在with editior，不知道结果咋样呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cba95534093, createdName=ms3000000025379696, createdTime=Mon Sep 06 16:55:23 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2144585, encodeId=be622144585ab, content=避雷吧，一审给了修，补完实验修回被编辑以卡出文量为由秒拒，太无理了这期刊，浪费两个多月时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c3b8599921, createdName=ms5000000162909074, createdTime=Sun Jun 25 08:48:11 CST 2023, time=2023-06-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2133771, encodeId=8b212133e713a, content=偏重的研究方向：药理学;药学 经验分享：这个期刊，补充材料怎么上传？没有专门的一栏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ffddvddvgh, createdTime=Sun May 14 19:57:28 CST 2023, time=2023-05-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2098645, encodeId=f9222098645a5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：八月下旬投稿，九月中旬一审完，被拒稿。四个审稿人推测应该都是大修（反正都没有说reject），但是编辑拒了，给了重投的机会。想赶紧发文章等的好煎熬啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbd48164181, createdName=ms3000002005636194, createdTime=Sat Nov 05 08:06:07 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128165, encodeId=731f2128165aa, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:08:44 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128164, encodeId=27af21281645f, content=。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Tue Apr 25 03:07:56 CST 2023, time=2023-04-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=558127, encodeId=7ae355812eeb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2018年5月31日投稿.到今天2018.6.20还处于with Editor状态文章编号ASPB 2048.381 Editor:Yin Liu, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/31/79cde2b0bbe4e92cd5bf6448af8c7491.jpg, createdBy=15162204908, createdName=奔跑在Nature路上的小兽医, createdTime=Wed Jun 20 16:18:00 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093129, encodeId=65ac2093129ac, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Tue Oct 11 15:36:33 CST 2022, time=2022-10-11, status=1, ipAttribution=)]

2022-10-11 ms6000001594127539

投稿命中率:5.0
偏重的研究方向：药理学
经验分享：9月底投的综述，1号还是2号开始with editor，过了几天status data变了一下，状态不变。课题组之前投的research article被拒非常快，都没有超过五天的，最快的一次都没满24h...我是不是可以理解有希望送审...

49 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务